NZX-listed Rua Bioscience has become the second New Zealand medical cannabis company to receive Good Manufacturing Practice (GMP) certification from Medsafe, a significant step towards production.
In July Helius Therapeutics was the first entity to receive GMP certification, the global standard
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
